SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-038321
Filing Date
2021-07-27
Accepted
2021-07-27 17:06:16
Documents
12
Period of Report
2021-07-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ljpc-8k_20210721.htm   iXBRL 8-K 100080
  Complete submission text file 0001564590-21-038321.txt   231298

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20210721.xsd EX-101.SCH 5737
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20210721_lab.xml EX-101.LAB 19337
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20210721_pre.xml EX-101.PRE 11527
5 EXTRACTED XBRL INSTANCE DOCUMENT ljpc-8k_20210721_htm.xml XML 3551
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 211118515
SIC: 2836 Biological Products, (No Diagnostic Substances)